Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia

Department of Human Genetics, Emory University School of Medicine, Atlanta 30322, GA, USA.
Human Genetics (Impact Factor: 4.82). 04/2011; 130(5):635-43. DOI: 10.1007/s00439-011-0989-6
Source: PubMed


Dopamine β-hydroxylase (DβH) catalyzes the conversion of dopamine to norepinephrine. DβH enters the plasma after vesicular release from sympathetic neurons and the adrenal medulla. Plasma DβH activity (pDβH) varies widely among individuals, and genetic inheritance regulates that variation. Linkage studies suggested strong linkage of pDβH to ABO on 9q34, and positive evidence for linkage to the complement fixation locus on 19p13.2-13.3. Subsequent association studies strongly supported DBH, which maps adjacent to ABO, as the locus regulating a large proportion of the heritable variation in pDβH. Prior studies have suggested that variation in pDβH, or genetic variants at DβH, associate with differences in expression of psychotic symptoms in patients with schizophrenia and other idiopathic or drug-induced brain disorders, suggesting that DBH might be a genetic modifier of psychotic symptoms. As a first step toward investigating that hypothesis, we performed linkage analysis on pDβH in patients with schizophrenia and their relatives. The results strongly confirm linkage of markers at DBH to pDβH under several models (maximum multipoint LOD score, 6.33), but find no evidence to support linkage anywhere on chromosome 19. Accounting for the contributions to the linkage signal of three SNPs at DBH, rs1611115, rs1611122, and rs6271 reduced but did not eliminate the linkage peak, whereas accounting for all SNPs near DBH eliminated the signal entirely. Analysis of markers genome-wide uncovered positive evidence for linkage between markers at chromosome 20p12 (multi-point LOD = 3.1 at 27.2 cM). The present results provide the first direct evidence for linkage between DBH and pDβH, suggest that rs1611115, rs1611122, rs6271 and additional unidentified variants at or near DBH contribute to the genetic regulation of pDβH, and suggest that a locus near 20p12 also influences pDβH.

Download full-text


Available from: Robert Elston,
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dopamine-ß-Hydroxylase (DBH) is an oxidase enzyme that catalyzes the conversion of dopamine to norepinephrine. Serum DBH level is suggested to be a useful measure of the function of the sympathetic nervous system. The enzymatic activity of DBH is measured by its action upon Tyramine. The product is determined by different techniques including colorimetery, high performance liquid chromatography (HPLC) and radioimmunoassay (RIA). However, these techniques are time consuming especially when dealing with a large number of samples. In the present study, we modified the colorimetric DBH assay by utilizing batch adsorption method instead of ion exchange column chromatography that is used in the classical technique. The results showed that the new method is sensitive, reliable and require less time in assaying DBH activity. The new method was used to assay enzyme activity in normal children and those suffering from attention deficit and hyperactivity disorder (ADHD). Significant differences were observed in the level of DBH between the two groups, which is typical for ADHD. Thus, the new assay is a valid method for measuring serum DBH activity.
    International Journal of Integrative Biology 01/2011; 12(1):11-14.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: With a worldwide prevalence of ~5%, attention deficit hyperactivity disorder (ADHD) has become one of the most common psychiatric disorders. The polygenetic nature of ADHD indicates that multiple genes jointly contribute to the development of this complex disease. Studies aiming to explore genetic susceptibility of ADHD have been increasing in recent years. There is a growing need to integrate the genetic data from various genetic studies to provide a comprehensive data set and uniform access for convenience of in-depth data mining. So far, there has been no such effort for ADHD. To address the genetic complexity of ADHD, we developed the ADHDgene database by integrating ADHD-related genetic factors by profound literature reading. Based on the data from the literature, extended functional analysis, including linkage disequilibrium analysis, pathway-based analysis and gene mapping were performed to provide new insights into genetic causes of ADHD. Moreover, powerful search tools and a graphical browser were developed to facilitate the navigation of the data and data connections. As the first genetic database for ADHD, ADHDgene aims to provide researchers with a central genetic resource and analysis platform for ADHD and is freely available at
    Nucleic Acids Research 11/2011; 40(Database issue):D1003-9. DOI:10.1093/nar/gkr992 · 9.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: For both model-free and model-based linkage analysis the S.A.G.E. (Statistical Analysis for Genetic Epidemiology) program package has some unique capabilities in analyzing both continuous traits and binary traits with variable age of onset. Here we highlight model-based linkage analysis of a quantitative trait (plasma dopamine β hydroxylase) that is known to be largely determined by monogenic inheritance, using a prior segregation analysis to produce the best fitting model for the trait. For a binary trait with variable age of onset (schizophrenia), we illustrate how using age of onset information to obtain a quantitative susceptibility trait leads to more statistically significant linkage signals, suggesting better power.
    Human Heredity 12/2011; 72(4):237-46. DOI:10.1159/000331672 · 1.47 Impact Factor
Show more